Post-Operative Pain Therapeutics Market Size to Exceed US$ 20.6 Billion by 2030

The global Post-Operative Pain Therapeutics market is estimated to develop at a compound annual growth rate (CAGR) of 6.2%. The global Post-Operative Pain Therapeutics market size was valued at USD 12.1 billion in 2021, and it is predicted to exceed USD 20.6  billionby 2030. The study investigates several elements and their consequences on the growth of the Post-Operative Pain Therapeutics market.

Full Report is Ready | Request Sample of This Report @ https://www.novaoneadvisor.com/report/sample/6362

Increase in surgical procedures followed by post-surgical problems is anticipated to drive the global post-operative pain therapeutics market during the forecast period. Key players focus on manufacturing of cost-effective post-operative pain therapeutics. The global post-operative pain therapeutics market is expected to be driven by increase in the number of elderly patients, rise in prevalence of diseases, surge in number of regulatory approvals, and demand for post-operative pain therapeutics.

Asia Pacific held major share of the global post-operative pain therapeutics market in 2020 due to the presence of large number of key players, rise in demand for post-operative pain therapeutics, and increase in elderly patients. The post-operative pain therapeutics market in Asia Pacific is expected to expand at a CAGR of 6.7% from 2022 to 2030 owing to surge in number of elderly patients and increase in product approvals from regulatory authorities. This, in turn, is likely to drive the demand for post-operative pain therapeutics in emerging markets such as India and China.

Report Scope of the Post-operative Pain Therapeutics Market

Advent of New Technology to Drive Global Market

The postoperative pain therapeutics market has witnessed significant investments by multinational corporates in the past few years. These business conglomerates have invested in companies operating in the postoperative pain therapeutics market. Camurus AB announced that the regulatory agency of Australia, the Therapeutic Goods Administration (TGA), approved key label updates to Buvidal Weekly and Buvidal Monthly (buprenorphine) modified-release solutions for injection for the treatment of opioid dependence.

PaciraBioSciences, Inc. received the FDA approval for its supplemental new drug application (sNDA) to broaden the use of EXPAREL (bupivacaine liposome injectable suspension) to include administration via interscalene brachial plexus block to produce postsurgical regional analgesia. Trevena announced FDA approval for OLINVYK (oliceridine) injection. OLINVYK is a new chemical entity approved in adults for the management of acute pain severe enough to require an IV opioid analgesic.

Pfizer, Inc. focuses on the development of biosimilar formulations in key therapeutic areas, owing to its potential to improve patient care by extending access to high quality, effective, and targeted treatment for multiple serious and chronic diseases.

Full Report is Ready |Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/6362

Opioids Dominated Post-operative Pain Therapeutics Market

In terms of drug class, the global post-operative pain therapeutics market has been classified into opioids, NSAIDS, local anesthetics, tricyclic antidepressants, antiepileptic drugs, and others. The opioids segment dominated the global post-operative pain therapeutics market in 2020 and the trend is projected to continue during the forecast period. Increase in demand for opioids is expected to drive the segment over the next few years.

Oral Preferred Route of Administration

In terms of route of administration, the global post-operative pain therapeutics market has been categorized into oral, intramuscular, intravenous, and others. The oral segment dominated the global post-operative pain therapeutics market in 2020, and the trend is projected to continue during the forecast period.

Hospital Pharmacies to be Lucrative Distribution Channel

In terms of distribution channel, the global post-operative pain therapeutics market has been divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment held major share of the global post-operative pain therapeutics market in 2020.

Asia Pacific to Lead Global Market

In terms of region, the global post-operative pain therapeutics market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Asia Pacific is projected to account for leading share of the global post-operative pain therapeutics market during the forecast period, owing to increase in number of patients suffering from chronic diseases in hospitals. The post-operative pain therapeutics market in Asia Pacific is projected to grow at a rapid pace in the next few years. India, China, and South Korea are expected to be lucrative markets in the near future.

Some of the prominent players in the Post-Operative Pain Therapeutics market include:

• Allergan plc
• Bayer AG
• Camarus
• Eli Lilly & Company
• Egalet Corporation
• Endo International plc
• Janssen Pharmaceuticals, Inc.
• GlaxoSmithKline plc
• Mallinckrodt Pharmaceuticals
• Mylan N.V.
• Novartis AG
• Pacira Pharmaceuticals, Inc.
• Pfizer, Inc.
• Purdue Pharma L.P
• Teva Pharmaceutical Industries Ltd.
• Trevena, Inc.

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

Global Post-operative Pain Therapeutics Market: Segmentation

• Post-operative Pain Therapeutics Market, by Drug Class
  • Opioids
  • NSAIDS
  • Local Anesthetics
  • Tricyclic Antidepressants
  • Antiepileptic Drugs
  • Others
• Post-operative Pain Therapeutics Market, by Route of Administration
  • Oral
  • Intramuscular
  • Intravenous
  • Others
• Post-operative Pain Therapeutics Market, by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Click Here to View Full Report Table of Contents

Key Questions Answered in Post-Operative Pain Therapeutics Market Report

What will be the sales/revenue generated by Post-Operative Pain Therapeutics across all regions during the forecast period?

What are the opportunities in the global Post-Operative Pain Therapeutics market?

What are the major drivers, restraints, opportunities, and threats in the market?

Which regional market is set to expand at the fastest CAGR during the forecast period?

Which application is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?

What is the market position of different companies operating in the global market?

Full Report is Ready |Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/6362

You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. We endeavor to give our clients latest insights on upcoming technologies, new developing markets, dynamically changing business conditions and most recent business-driven applications. These insights help our clients to take informed decisions for their business growth. We for the most part center around supporting our clients with aggressive insight, helping them to anchor an upper hand in the market and achieve reasonable development in various market spaces. Capable with an exceedingly skilled, experienced and to a great degree qualified group of specialists including SMEs, investigators and advisors, we attempt to provide value-added business solutions to our customers. Through dedicated subjective and quantitative market research techniques and supporting consulting assignments, we adeptly formulate competitive strategies to address business challenges for our customers through investigating market drifts, trends and rising advances in emerging technologies.

For Latest Update Follow Us:

https://www.linkedin.com/company/nova-one-advisor

https://twitter.com/NovaOneAdvisor

https://www.facebook.com/Nova-One-Advisor-116142276949837/